A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease

Cited by (999)

Items 301–400 of 999

1. Vasodilator Stress CMR and All-Cause Mortality in Stable Ischemic Heart Disease: A Large Retrospective Registry.
   V. Marcos-Garcés, J. Gavara, J. Monmeneu, M. López-Lereu, M. J. Bosch, P. Merlos, N. Pérez, C. Ríos-Navarro, E. de Dios, C. Bonanad et al. · 2020 · JACC Cardiovascular Imaging
2. A Meta-analysis of Randomized Controlled Trials Comparing Percutaneous Coronary Intervention With Medical Therapy in Stable Angina Pectoris
   Sabu Thomas, Rohit Gokhale, William E. Boden, Philip James Devereaux · 2012 · Canadian Journal of Cardiology
3. Diabetic cardiovascular autonomic neuropathy: clinical implications
   Georgios Karayannis, Grigorios Giamouzis, Dennis V. Cokkinos, John S. Skoularigis, Filippos K. Triposkiadis · 2012 · Expert Review of Cardiovascular Therapy
4. Serial myocardial perfusion imaging: defining a significant change and targeting management decisions.
   A. Iskandrian, F. Hage, L. Shaw, J. Mahmarian, D. Berman · 2014 · JACC Cardiovascular Imaging
5. Cardiac hybrid imaging
   Oliver Gaemperli, Antti Saraste, Juhani M. Knuuti · 2011 · European Heart Journal - Cardiovascular Imaging
6. Fractional Flow Assessment for the Evaluation of Intracranial Atherosclerosis: A Feasibility Study
   Zhongrong Miao, David S. Liebeskind, Wai-Ting Lo, Liping Liu, Yuehua Pu, Xinyi Leng, Ligang Song, Xiaotong Xu, Baixue Jia, Feng Gao et al. · 2016 · Interventional Neurology
7. Diabetes Exacerbates Myocardial Ischemia/Reperfusion Injury by Down-Regulation of MicroRNA and Up-Regulation of O-GlcNAcylation
   Dandan Wang, Xiaoyue Hu, Seung Hee Lee, Feng Chen, Kai Jiang, Zizhuo Tu, Zejian Liu, Jing Du, Li Wang, Chaoying Yin et al. · 2018 · JACC Basic to Translational Science
8. Healthy Behavior, Risk Factor Control, and Survival in the COURAGE Trial
   David Joel Maron, G.B. John Mancini, Pamela M. Hartigan, John A. Spertus, Steven P. Sedlis, William J. Kostuk, Daniel S. Berman, Koon Kang Teo, William S. Weintraub, William E. Boden · 2018 · Journal of the American College of Cardiology
9. Prevalent and incident heart failure in cardiovascular outcome trials of patients with type 2 diabetes.
   Greene, Stephen J., Vaduganathan, Muthiah, Khan, Muhammad Shahzeb, Bakris, George L., Weir, Matthew R., Seltzer, Jonathan H., Sattar, Naveed, McGuire, Darren K., Januzzi, James L., Stockbridge, Norman et al. · 2018 · Journal of the American College of Cardiology
10. Ischemia Change in Stable Coronary Artery Disease Is an Independent Predictor of Death and Myocardial Infarction
    Afshin Farzaneh‐Far, Harry R. Phillips, Linda K. Shaw, Aijing Z. Starr, Mona Fiuzat, Christopher M. O’Connor, Ashwani Sastry, Leslee J. Shaw, Salvador Borges‐Neto · 2012 · JACC. Cardiovascular imaging
11. Dysglycaemia, vasculopenia, and the chronic consequences of diabetes
    Hertzel C. Gerstein, Geoff H. Werstuck · 2013 · The Lancet Diabetes & Endocrinology
12. Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology/Canadian Society of Cardiac Surgery Position Statement on Revascularization—Multivessel Coronary Artery Disease
    Koon Kang Teo, Eric A. Cohen, Christopher E.H. Buller, Ansar Hassan, Ronald Giacomo Carere, Jafna L. Cox, Hung Q. Ly, Paul W.M. Fedak, Kwan Leung Chan, Jean‐François Légaré et al. · 2014 · Canadian Journal of Cardiology
13. Diagnosing coronary artery disease with hybrid PET/CT: It takes two to tango
    Ibrahim Danad, Pieter G.H.M. Raijmakers, Paul Knaapen · 2013 · Journal of Nuclear Cardiology
14. Insulin Resistance Impairs Circulating Angiogenic Progenitor Cell Function and Delays Endothelial Regeneration
    Matthew Kahn, Nadira Y. Yuldasheva, Richard M. Cubbon, Jessica Smith, Sheikh Tawqeer Rashid, Hema Viswambharan, Helen Imrie, Afroze Abbas, Adil Rajwani, Amir Aziz et al. · 2011 · Diabetes
15. Non-invasive screening for coronary artery disease in asymptomatic diabetic patients: a systematic review and meta-analysis of randomised controlled trials
    Olivier Florian Clerc, Tobias Andreas Fuchs, Julia Stehli, Dominik C. Benz, Christoph Gräni, Michael Messerli, Andreas A. Giannopoulos, Ronny R. Buechel, Thomas Felix Lüscher, Aju Paul Pazhenkottil et al. · 2018 · European Heart Journal - Cardiovascular Imaging
16. Effect of glucose-lowering therapies on heart failure
    Michael E. Nassif, Mikhail Kosiborod · 2018 · Nature Reviews Cardiology
17. Diabetes mellitus type 2 in adults
    Ivan Ivanovich Dedov, Marina Vladimirovna Shestakova, Alexander Yu. Mayorov, Минара Шамхаловна Шамхалова, Olga Yu. Sukhareva, Gagik Radikovich Galstyan, Alla Yur'evna Tokmakova, Tatiana Vasil'evna Nikonova, Elena Viktorovna Surkova, Ирина Владимировна Кононенко et al. · 2020 · Diabetes Mellitus
18. Routine Assessment of On-Clopidogrel Platelet Reactivity and Gene Polymorphisms in Predicting Clinical Outcome Following Drug-Eluting Stent Implantation in Patients With Stable Coronary Artery Disease
    Chiara Viviani Anselmi, Carlo Briguori, Roberta Roncarati, Laura Papa, Gabriella Visconti, Amelia Focaccio, Francesca De Micco, Michael V.G. Latronico, Paolo Antonio Pagnotta, Gianluigi Condorelli · 2013 · JACC: Cardiovascular Interventions
19. Assessment of Nonfatal Myocardial Infarction as a Surrogate for All-Cause and Cardiovascular Mortality in Treatment or Prevention of Coronary Artery Disease
    Kevin O’Fee, Elena Deych, Oriana Ciani, David Brown · 2021 · JAMA Internal Medicine
20. Economic Outcomes of Treatment Strategies for Type 2 Diabetes Mellitus and Coronary Artery Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial
    Mark Andrew Hlatky, Derek B. Boothroyd, Kathryn A. Melsop, Laurence Kennedy, Charanjit S. Rihal, William J. Rogers, Lakshmi Venkitachalam, Maria M. Brooks · 2009 · Circulation
21. Angiographic Disease Progression and Residual Risk of Cardiovascular Events While on Optimal Medical Therapy
    G.B. John Mancini, Pamela M. Hartigan, Eric Bates, Steven P. Sedlis, David Joel Maron, John A. Spertus, Daniel S. Berman, William J. Kostuk, Leslee J. Shaw, William S. Weintraub et al. · 2011 · Circulation Cardiovascular Interventions
22. Thiazolidinediones: A 2010 Perspective
    Ashok Krishnaswami, Shalini Ravi-Kumar, John M Lewis · 2010 · The Permanente Journal
23. Estimated insulin sensitivity predicts incident micro- and macrovascular complications in adults with type 1 diabetes over 6 years: the coronary artery calcification in type 1 diabetes study
    Petter Bjornstad, David M. Maahs, Lindsey M. Duca, Laura Pyle, Marian Rewers, Richard J. Johnson, Janet K. Snell‐Bergeon · 2016 · Journal of Diabetes and its Complications
24. Myocardial Revascularization Surgery
    Michael J. Mack, John J. Squiers, Bruce Whitney Lytle, John Michael DiMaio, Friedrich Wilhelm Mohr · 2021 · Journal of the American College of Cardiology
25. Coronary Computed Tomographic Angiographic Findings in Asymptomatic Patients With Type 2 Diabetes Mellitus
    Gyung‐Min Park, Seung‐Whan Lee, Young–Rak Cho, Chan Joon Kim, Jung Sun Cho, Mahn‐Won Park, Sung‐Ho Her, Jung‐Min Ahn, Jong‐Young Lee, Duk‐Woo Park et al. · 2013 · The American Journal of Cardiology
26. Predictors, Trends, and Outcomes (Among Older Patients ≥65 Years of Age) Associated With Beta-Blocker Use in Patients With Stable Angina Undergoing Elective Percutaneous Coronary Intervention
    Apurva A. Motivala, Valay K. Parikh, Matthew T. Roe, David Dai, Jinnette Dawn Abbott, Abhiram Prasad, Debabrata Mukherjee · 2016 · JACC: Cardiovascular Interventions
27. Current approach to the diagnosis of atherosclerotic coronary artery disease: more questions than answers
    Adam J. Nelson, Maddalena Ardissino, Peter James Psaltis · 2019 · Therapeutic Advances in Chronic Disease
28. Optimizing Management of Stable Angina
    Rocco Antonio Montone, Riccardo Rinaldi, Giampaolo Niccoli, Giuseppe Andò, Felice Gragnano, Raffaele Piccolo, Francesco Pelliccia, Elisabetta Moscarella, Marco Zimarino, Enrico Fabris et al. · 2024 · Journal of the American College of Cardiology
29. Revascularization in Severe Left Ventricular Dysfunction
    Eric J. Velazquez, Robert O. Bonow · 2015 · Journal of the American College of Cardiology
30. Impact of Hypoglycemia in Hospitalized Patients
    Michelle Carey, Laura Boucai, Joel Zonszein · 2012 · Current Diabetes Reports
31. Clinical significance of noninvasive coronary flow reserve assessment in patients with ischemic heart disease
    Viviany R. Taqueti, Marcelo F. Di Carli · 2016 · Current Opinion in Cardiology
32. Hybrid SPECT Perfusion Imaging and Coronary CT Angiography: Long-term Prognostic Value for Cardiovascular Outcomes
    Aju Paul Pazhenkottil, Dominik C. Benz, Christoph Gräni, Michael Alle Madsen, Fran Mikulicic, Elia von Felten, Tobias Andreas Fuchs, Beatrice Hirt Moch, Julia Stehli, Thomas Felix Lüscher et al. · 2018 · Radiology
33. Type 2 diabetes and coronary artery disease: Preserved ejection fraction and sudden cardiac death
    Juhani M. Junttila, Antti M. Kiviniemi, E. Samuli Lepojärvi, Mikko Paavo Tulppo, Olli-Pekka Piira, Tuomas V Kenttä, Juha S. Perkiömäki, Olavi H. Ukkola, Robert J. Myerburg, Heikki V. Huikuri · 2018 · Heart Rhythm
34. Risk stratification and screening for coronary artery disease in asymptomatic patients with diabetes mellitus: Position paper of the French Society of Cardiology and the French-speaking Society of Diabetology
    Paul Elie Valensi, Patrick Henry, Franck Boccara, Emmanuel Cosson, Gaëtan Prévost, Joseph Emmerich, Laura Ernande, Dany Michel Marcadet, Élie Mousseaux, François Rouzet et al. · 2020 · Diabetes & Metabolism
35. Coronary Artery Bypass Revascularization Using Bilateral Internal Thoracic Arteries in Diabetic Patients: A Systematic Review and Meta-Analysis
    Kajimoto, Kan, Yamamoto, Taira, Amano, Atsushi · 2015 · The Annals of Thoracic Surgery
36. Individualized glycaemic targets and pharmacotherapy in type 2 diabetes
    Clifford J. Bailey, Pablo J. Aschner, Stefano Del Prato, James R. LaSalle, Linong Ji, Stephan Matthaei, on behalf of the Global Partnership for Effective Diabetes Management · 2013 · Diabetes and Vascular Disease Research
37. Physiological and Metabolic Effects of Grafts in Coronary Artery Bypass Surgery
    Soichiro Kitamura · 2011 · Circulation Journal
38. Impact of Complete Revascularization in the ISCHEMIA Trial
    Gregg W. Stone, Ziad A. Ali, Sean M. O’Brien, Grace L. Rhodes, Philippe Généreux, Sripal Bangalore, Kreton Mavromatis, Jennifer A. Horst, Ovidiu Dressler, Kian Keong Poh et al. · 2023 · Journal of the American College of Cardiology
39. Future Directions for Cardiovascular Disease Comparative Effectiveness Research
    Mark Andrew Hlatky, Pamela S. Douglas, Nakela L. Cook, Barbara L. Wells, Emelia J. Benjamin, Kay Dickersin, David Calvin Goff, Alan T. Hirsch, Elaine M. Hylek, Eric David Peterson et al. · 2012 · Journal of the American College of Cardiology
40. Prognostic Determinants of Coronary Atherosclerosis in Stable Ischemic Heart Disease
    Amir Ali Ahmadi, Gregg W. Stone, Jonathon A Leipsic, Leslee J. Shaw, Todd C. Villines, Morton J. Kern, Harvey S. Hecht, David Erlinge, Ori Ben‐Yehuda, Akiko Maehara et al. · 2016 · Circulation Research
41. DIRETRIZ DA SOCIEDADE BRASILEIRA DE CARDIOLOGIA E DA SOCIEDADE BRASILEIRA DE HEMODINÂMICA E CARDIOLOGIA INTERVENCIONISTA SOBRE INTERVENÇÃO CORONÁRIA PERCUTÂNEA
    Fausto Feres, Costa Ra, Dimytri Siqueira, JR Costa Jr, Daniel Chamié, Rodolfo Staico, Chaves Aj, Alexandre Abizaid, José Antônio Marin‐Neto, Anis Rassi et al. · 2017 · Arquivos Brasileiros de Cardiologia
42. Efficacy of noninvasive cardiac imaging tests in diagnosis and management of stable coronary artery disease
    Ify R. Mordi, Athar Badar, R Irving, Jonathan Richard Weir-McCall, J. Graeme Houston, Chim Choy Lang · 2017 · Vascular Health and Risk Management
43. Type 2 Diabetes Mellitus
    Kenneth S. Polonsky, Charles Burant · 2016 · Elsevier eBooks
44. Prognostic Impact of the Presence and Absence of Angina on Mortality and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Stable Coronary Artery Disease
    Gilles R. Dagenais, Jiang Lu, David P. Faxon, Peter M. Bogaty, Dale S. Adler, Francisco J. Fuentes, Jorge Escobedo, Ashok Krishnaswami, James N. Slater, Robert L. Frye · 2013 · Journal of the American College of Cardiology
45. Association of Metformin with the Mortality and Incidence of Cardiovascular Events in Patients with Pre-existing Cardiovascular Diseases
    Tian Li, Rui Andre Providencia, Wenhua Jiang, Nan Mu, Yishi Wang, Xiaokang Li, Yue Yin, Manling Liu, Lu Yu, Chunhu Gu et al. · 2022 · Drugs
46. Novel Approaches for Preventing or Limiting Events in Diabetic Patients (Naples-Diabetes) Trial
    Carlo Briguori, Flavio Airoldi, Gabriella Visconti, Amelia Focaccio, Gianluca Caiazzo, Bruno Golia, Giuseppe Biondi‐Zoccai, Bruno Ricciardelli, Gerolama Condorelli · 2011 · Circulation Cardiovascular Interventions
47. The adequacy of myocardial revascularization in patients with multivessel coronary artery disease
    Marco Zimarino, Nick P. Curzen, Vincenzo Cicchitti, Raffaele De Caterina · 2013 · International Journal of Cardiology
48. Should Sulfonylureas Remain an Acceptable First-Line Add-on to Metformin Therapy in Patients With Type 2 Diabetes? Yes, They Continue to Serve Us Well!
    Martin J. Abrahamson · 2014 · Diabetes Care
49. Prevalence and Predictors of Ischemia and Outcomes in Outpatients With Diabetes Mellitus Referred for Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging
    Jamieson MacDonald Bourque, Chetan A. Patel, Mohamed Mandour Ali, Margarita Perez, Denny D. Watson, George Beller · 2013 · Circulation Cardiovascular Imaging
50. Management of Stable Angina – Current Guidelines: A Critical Appraisal
    Udho Thadani · 2016 · Cardiovascular Drugs and Therapy
51. Health Status After Treatment for Coronary Artery Disease and Type 2 Diabetes Mellitus in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial
    Maria M. Brooks, Sheng‐Chia Chung, Tarek A. Helmy, William B. Hillegass, Jorge Escobedo, Kathryn A. Melsop, Elaine M. Massaro, Robert D. McBane, Pamela Hyde, Mark Andrew Hlatky et al. · 2010 · Circulation
52. Noninvasive Coronary Atherosclerotic Plaque Imaging
    Jacek Kwieciński, Evangelos Tzolos, Michelle Claire Williams, Damini Dey, Daniel S. Berman, Piotr J. Slomka, David Ernest Newby, Marc Richard Dweck · 2023 · JACC. Cardiovascular imaging
53. The role of radionuclide myocardial perfusion imaging for asymptomatic individuals
    Robert C. Hendel, Brian Abbott, Timothy M. Bateman, Ron Blankstein, Dennis A. Calnon, Jeffrey A. Leppo, Jamshid Maddahi, Matthew M. Schumaecker, Leslee J. Shaw, R. Parker Ward et al. · 2010 · Journal of Nuclear Cardiology
54. Clinical significance of chronic myocardial ischemia in coronary artery disease patients
    Paulo Cury Rezende, Fernando Faglioni Ribas, Carlos Vicente Serrano Junior, Whady Armindo Hueb · 2019 · Journal of Thoracic Disease
55. Contemporary rationale for non-invasive imaging of adverse coronary plaque features to identify the vulnerable patient: a Position Paper from the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology and the European Association of Cardiovascular Imaging
    Marc Richard Dweck, Pál Maurovich‐Horvat, Tim Leiner, Bernard Cosyns, Zahi Adel Fayad, Frank J H Gijsen, Kim Van der Heiden, M. Eline Kooi, Akiko Maehara, James E. Muller et al. · 2020 · European Heart Journal - Cardiovascular Imaging
56. Optimal revascularization for complex coronary artery disease
    Javaid Iqbal, Patrick W.J.C. Serruys, David Paul Taggart · 2013 · Nature Reviews Cardiology
57. Top 10 cardiovascular therapies and interventions for the next decade
    Valentı́n Fuster · 2014 · Nature Reviews Cardiology
58. A Genetic Locus on Chromosome 2q24 Predicting Peripheral Neuropathy Risk in Type 2 Diabetes: Results From the ACCORD and BARI 2D Studies
    Yaling Tang, Petra A. Lenzini, Rodica Pop‐Busui, Pradipta Ray, Hannah Campbell, Bruce A. Perkins, Brian Christopher Callaghan, Michael J. Wagner, Alison A. Motsinger‐Reif, John B. Buse et al. · 2019 · Diabetes
59. Benefit of Early Revascularization Based on Inducible Ischemia and Left Ventricular Ejection Fraction
    Alan Rozanski, Robert J.H. Miller, Heidi Gransar, Donghee Han, Piotr J. Slomka, Damini Dey, Sean W. Hayes, John D. Friedman, Louise Thomson, Daniel S. Berman · 2022 · Journal of the American College of Cardiology
60. Multimodality imaging in ischaemic heart failure.
    Jeroen J. Bax, M. D. di Carli, J. Narula, V. Delgado · 2019 · The Lancet
61. Ischemic Burden Reduction and Long-Term Clinical Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention
    Stefan P. Schumacher, Wijnand J. Stuijfzand, Ruben W. de Winter, Pepijn A. van Diemen, Michiel J. Bom, Henk Everaars, Roel S. Driessen, Lara Kamperman, Marly Kockx, Bram S.H. Hagen et al. · 2021 · JACC: Cardiovascular Interventions
62. Predicting Cardiovascular Risk in Type 2 Diabetes: the Heterogeneity Challenges
    Maria Odette Gore, Darren K. McGuire, Ildiko Lingvay, Julio Rosenstock · 2015 · Current Cardiology Reports
63. The links between complex coronary disease, cerebrovascular disease, and degenerative brain disease
    Jason Ciril Kovacic, Jose Maria Castellano, Valentı́n Fuster · 2012 · Annals of the New York Academy of Sciences
64. Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial
    Lund, S. S, Tarnow, L., Frandsen, M., Nielsen, B. B, Hansen, B. V, Pedersen, O., Parving, H.-H., Vaag, A. A · 2009 · BMJ
65. Paradigm Shift to Functional Angioplasty
    Seung‐Jung Park, Jung‐Min Ahn, Soo‐Jin Kang · 2011 · Circulation
66. Lessons learned from MPI and physiologic testing in randomized trials of stable ischemic heart disease: COURAGE, BARI 2D, FAME, and ISCHEMIA
    Lawrence M. Phillips, Rory Hachamovitch, Daniel S. Berman, Ami E. Iskandrian, James K. Min, Michael H. Picard, Raymond Y.K. Kwong, Matthias G. Friedrich, Marielle Scherrer‐Crosbie, Sean W. Hayes et al. · 2013 · Journal of Nuclear Cardiology
67. Guía de práctica clínica de la ESC para el manejo del síndrome coronario agudo en pacientes sin elevación persistente del segmento ST
    Christian W. Hamm, Jean‐Pierre Bassand, Stefan Agewall, Jeroen Joost Bax, Eric H. Boersma, Héctor Bueno, Pio Caso, Dariusz Dudek, Stephan Gielen, Kurt Huber et al. · 2012 · Revista Española de Cardiología
68. Relationship between preoperative hemoglobin A1c levels and long-term mortality after coronary artery bypass grafting in patients with type 2 diabetes mellitus
    Jeanette Kuhl, Ulrik Sartipy, Björn Eliasson, Thomas Nyström, Martin J. Holzmann · 2015 · International Journal of Cardiology
69. Cardiac hybrid imaging
    Oliver Gaemperli, Philipp Antonio Kaufmann, Hatem Alkadhi · 2014 · European Journal of Nuclear Medicine and Molecular Imaging
70. Association between admission hypoglycaemia and in-hospital and 3-year mortality in older patients with acute myocardial infarction
    Shih‐Wei Yang, Yujie Zhou, Daiyu Hu, Xiao-Min Nie, Yu-Yang Liu, Qi Hua, Xian Wang, Hong-Wei Li, for the BEAMIS Study Group · 2010 · Heart
71. Managing Coronary Artery Disease in the Cancer Patient
    Ronald J. Krone · 2010 · Progress in Cardiovascular Diseases
72. Stress Perfusion Cardiac Magnetic Resonance Imaging Effectively Risk Stratifies Diabetic Patients With Suspected Myocardial Ischemia
    Bobak Heydari, Yu‐Hsiang Juan, Hui Liu, Siddique A. Abbasi, Ravi V. Shah, Ron Blankstein, Michael L. Steigner, Michael Jerosch‐Herold, Raymond Y.K. Kwong · 2016 · Circulation Cardiovascular Imaging
73. Coronary artery disease and diabetes mellitus
    Mansour M. Al-Nozha, Hussein M Ismail, Omar Mansour Al Nozha · 2016 · Journal of Taibah University Medical Sciences
74. Combined evaluation of regional coronary artery calcium and myocardial perfusion by 82Rb PET/CT in predicting lesion-related outcome
    Emilia Zampella, Wanda Acampa, Roberta Assante, Valeria Gaudieri, Carmela Nappi, Teresa Mannarino, Ciro Gabriele Mainolfi, Parthiban Arumugam, Mario Petretta, Alberto Cuocolo · 2019 · European Journal of Nuclear Medicine and Molecular Imaging
75. Multimodality cardiac imaging in the 21st century: evolution, advances and future opportunities for innovation
    Melissa A. Daubert, Tina D. Tailor, Olga G James, Leslee J. Shaw, Pamela S. Douglas, Lynne Koweek · 2020 · British Journal of Radiology
76. The case for intervention bias in the practice of medicine.
    Andrew Foy, Edward John Filippone · 2013 · Europe PMC (PubMed Central)
77. Percutaneous Coronary Intervention in Patients With Diabetes
    Ehrin J. Armstrong, Johannes L. Waltenberger, Jason H. Rogers · 2014 · Journal of Diabetes Science and Technology
78. Cardiac Disease in Cancer Patients: An Overview
    Douglas L. Mann, Ronald J. Krone · 2010 · Progress in Cardiovascular Diseases
79. Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelines
    William E. Boden, Raffaele De Caterina, Juan Carlos Kaski, C. Noel Bairey Merz, Colin Berry, Mario Marzilli, Carl J. Pepine, Emanuele Barbato, Giulio Giuseppe Stefanini, Eva Prescott et al. · 2024 · European Heart Journal
80. HbA1c below 7 % as the goal of glucose control fails to maximize the cardiovascular benefits: a meta-analysis
    Pin Wang, Rong Huang, Sen Lu, Wenqing Xia, Haixia Sun, Jie Lena Sun, Rongrong Cai, Shaohua Wang · 2015 · Cardiovascular Diabetology
81. Weight Considerations in Pharmacotherapy for Type 2 Diabetes
    Vicky Cheng, Sangeeta Rao Kashyap · 2010 · Journal of Obesity
82. Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. The SMART study
    Sandra N. Verhagen, Annemarie M.J. Wassink, Yolanda van der Graaf, Petra M. Gorter, Frank L.J. Visseren, the SMART Study Group · 2011 · Cardiovascular Diabetology
83. Hospital Percutaneous Coronary Intervention Appropriateness and In-Hospital Procedural Outcomes
    Steven M. Bradley, Paul S. Chan, John A. Spertus, Kevin F. Kennedy, Pamela S. Douglas, Manesh R. Patel, H. Vernon Anderson, Henry H. Ting, John S. Rumsfeld, Brahmajee K. Nallamothu · 2012 · Circulation Cardiovascular Quality and Outcomes
84. The Effect of Age on Clinical Outcomes and Health Status
    Sheng‐Chia Chung, Mark Andrew Hlatky, David P. Faxon, Kodangudi B. Ramanathan, Dale S. Adler, Arshag D. Mooradian, Charanjit S. Rihal, Roslyn A. Stone, Joyce T. Bromberger, Sheryl F. Kelsey et al. · 2011 · Journal of the American College of Cardiology
85. Atherogenic dyslipidemia and diabetes mellitus: what’s new in the management arena?
    Ajoy Kumar · 2010 · Vascular Health and Risk Management
86. Influence of Diabetes Mellitus on Long-Term Clinical and Economic Outcomes After Coronary Artery Bypass Grafting
    Heng Zhang, Xin Yuan, Ruben L.J. Osnabrugge, Dejing Meng, Huawei Gao, Shiju Zhang, Chenfei Rao, Shengshou Hu, Zhe Zheng · 2014 · The Annals of Thoracic Surgery
87. Predictors and prognostic impact of silent coronary artery disease in asymptomatic high-risk patients with diabetes mellitus
    Michael Johannes Zellweger, Philip Haaf, Michael Maraun, Hans H. Osterhues, Ulrich Bernd Keller, Jan Müller‐Brand, Raban V. Jeger, Otmar Pfister, Miriam Brinkert, Thilo Burkard et al. · 2017 · International Journal of Cardiology
88. Death and Myocardial Infarction Following Initial Revascularization Versus Optimal Medical Therapy in Chronic Coronary Syndromes With Myocardial Ischemia: A Systematic Review and Meta‐Analysis of Contemporary Randomized Controlled Trials
    Andrea Soares, William E. Boden, Whady Armindo Hueb, Maria M. Brooks, Helen Vlachos, Kevin O’Fee, Angela Hardi, David Brown · 2021 · Journal of the American Heart Association
89. Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure
    Puja B. Parikh, Deepak L. Bhatt, Varun Bhasin, Stefan D. Anker, Hal A. Skopicki, Bimmer E.P.M. Claessen, Gregg C. Fonarow, Adrian F. Hernandez, Roxana Mehran, Mark Colquhoun Petrie et al. · 2021 · Journal of the American College of Cardiology
90. Nonischemic or Dual Cardiomyopathy in Patients With Coronary Artery Disease
    Parag Himmatrao Bawaskar, Nicholas Thomas, Khaled Ismail, Yugene Y. Guo, Sanya Chhikara, Pal Satyajit Singh Athwal, Alison N. Ranum, Achal Jadhav, Abel Hooker Mendez, Ishan Nadkarni et al. · 2023 · Circulation
91. Assessment of coronary artery disease risk in 5463 patients undergoing cardiac surgery: When is preoperative coronary angiography necessary?
    Nassir M Thalji, Rakesh M. Suri, Richard C. Daly, Joseph A. Dearani, Harold M. Burkhart, Soon J. Park, Kevin L. Greason, Lyle D. Joyce, John M. Stulak, Marianne Huebner et al. · 2013 · Journal of Thoracic and Cardiovascular Surgery
92. Myocardial Perfusion Reserve After a PET-Driven Revascularization Procedure: A Strong Prognostic Factor
    Riemer H. J. A. Slart, Clark J. Zeebregts, Hans L. Hillege, Johan DE SUTTER, Rudi Dierckx, Dirk Jan van Veldhuisen, Felix Zijlstra, René A. Tio · 2011 · Journal of Nuclear Medicine
93. Molecular imaging of plaque vulnerability
    Sina Tavakoli, Aseem Vashist, Mehran M. Sadeghi · 2014 · Journal of Nuclear Cardiology
94. Does coronary Atherosclerosis Deserve to be Diagnosed earlY in Diabetic patients? The DADDY-D trial. Screening diabetic patients for unknown coronary disease
    Fabrizio Turrini, Stefania Scarlini, Caterina Mannucci, R Messora, Paolo Giovanardi, Paolo Magnavacchi, Carlo Cappelli, Valeria Evandri, Andrea Zanasi, Stefania Romano et al. · 2015 · European Journal of Internal Medicine
95. Elevated glycated albumin and reduced endogenous secretory receptor for advanced glycation endproducts levels in serum predict major adverse cardio-cerebral events in patients with type 2 diabetes and stable coronary artery disease
    ZHEN KUN YANG, Ying H. Shen, Wei Feng Shen, Li Jin Pu, Hua Meng, Ruiyan Zhang, Qi Zhang, Qiujing Chen, Raffaele De Caterina, Lin Lu · 2015 · International Journal of Cardiology
96. Fractional Flow Reserve Derived from Coronary Computed Tomography Angiography Safely Defers Invasive Coronary Angiography in Patients with Stable Coronary Artery Disease
    Mark Rabbat, Jonathon A Leipsic, Jeroen Joost Bax, Brian Kauh, Rina Verma, Demetrios G. Doukas, Sorcha Allen, Gianluca Pontone, David J. Wilber, Verghese Mathew et al. · 2020 · Journal of Clinical Medicine
97. Metformin Impairs Vascular Endothelial Recovery After Stent Placement in the Setting of Locally Eluted Mammalian Target of Rapamycin Inhibitors Via S6 Kinase-Dependent Inhibition of Cell Proliferation
    Anwer Habib, Vinit Karmali, Rohini Polavarapu, Hirokuni Akahori, Masataka Nakano, Saami K. Yazdani, Fumiyuki Otsuka, Kim Pachura, Talina Davis, Jagat Narula et al. · 2013 · Journal of the American College of Cardiology
98. Xinyue Capsule in patients with stable coronary artery disease after percutaneous coronary intervention: a multicenter, randomized, placebo-controlled trial
    Ming Hao Guo, Peili Wang, Jianpeng Du, Changgeng Fu, Qiaoning Yang, Z Gao, Mingjun Zhu, Shuzheng Lv, Yue Deng, Tianchang Li et al. · 2020 · Pharmacological Research
99. A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease
    Greg L. Moneta · 2010 · Yearbook of Vascular Surgery
100. Diabetes with Coronary Disease — A Moving Target amid Evolving Therapies?
     William E. Boden, David Paul Taggart · 2009 · New England Journal of Medicine